Pegcetacoplan (SyfovreΤΜ): targeting complement C3 in geographic atrophy
Trends in Pharmacological Sciences · 2024-12 · 45 (12) · 1175-1176
DOI: 10.1016/j.tips.2024.10.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Pharmacological Sciences, 2024-12. Verfasst von Dimitrios C Mastellos und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Scientific Research 'Demokritos', Athens, Greece. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 10 Literaturangaben. Gefördert von: Merck KGaA.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- National Center for Scientific Research 'Demokritos', Athens, Greece.
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: lambris@pennmedicine.upenn.edu.
Förderung
- Merck KGaA
Zitieren
APA
Mastellos, D. C., & Lambris, J. D. (2024). Pegcetacoplan (SyfovreΤΜ): targeting complement C3 in geographic atrophy. Trends in Pharmacological Sciences, 45(12), 1175-1176. https://doi.org/10.1016/j.tips.2024.10.001
Vancouver
Mastellos DC, Lambris JD. Pegcetacoplan (SyfovreΤΜ): targeting complement C3 in geographic atrophy. Trends in Pharmacological Sciences. 2024;45(12):1175-1176. doi:10.1016/j.tips.2024.10.001
BibTeX
@article{Mastellos2024,
author = {Mastellos, Dimitrios C and Lambris, John D},
title = {Pegcetacoplan (SyfovreΤΜ): targeting complement C3 in geographic atrophy},
journal = {Trends in Pharmacological Sciences},
year = {2024},
volume = {45},
number = {12},
pages = {1175--1176},
doi = {10.1016/j.tips.2024.10.001}
}
EUVIMED